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Acute Obstructive Cholangitis after
Transarterial Chemoembolization: the
Effect of Percutaneous Transhepatic
Removal of Tumor Fragment 
Acute obstructive cholangitis due to the migration of necrotized tumor fragment
is a rare complication occurring after a transarterial chemoembolization. The per-
cutaneous tumor removal procedure following percutaneous transhepatic biliary
drainage is an appropriate treatment over endoscopic removal for the relief of
acute cholangitis in this case. Following this serial management, no invasive
hepatocellular carcinoma of the bile duct recurred after two years of follow-up. 
transcatheter arterial chemoembolization (TACE) is the ubiquitous
modality of choice for the treatment of hepatocellular carcinoma (HCC).
Following a TACE, some infrequent side effects and complications have
occurred and have been reported. The most common side effects are transient fever
and pain at one or two weeks after the TACE, the so-called post-embolization
syndrome. Other more infrequent complications, such as hepatic infarction and liver
abscess or biloma have also been reported. However, acute obstructive cholangitis,
due to the migration of completely necrotized tumor fragment after a TACE with
obstruction of the distal common bile duct (CBD), is rare. Following these serial
management, no recurred invasive HCC of the bile duct was observed over two years
of follow-up. We report a case of a successfully treated acute obstructive cholangitis
after TACE, due to the pathologically diagnosed, a total a total necrotic migrating
tumor fragment on a CBD, after an interventional percutaneous removal procedure.
CASE REPORT
A 62-year-old male visited the Department of Endocrinology to control his
hyperglycemia. The patient complained of intermittent fatigue, general aches, and
chills over the previous two months. Further, the patient had a history of HBV carrier
status, diabetes mellitus, and alcoholism over the last 20 years. The relevant labora-
tory results at the time of admission were as follows: glucose, 313 mg/dl; aspartate
aminotransferase, 96 IU/K; alanine transferase, 164 mg/dl; serum albumin, normal
range; alkaline phosphatase, 843 IU/dl (normal range, 103-335 IU/L); total serum
bilirubin, 2.3 mg/dl (normal range 0.2-1.2mg/dl); HBsAg, positive; HAV Ab-IgG,
positive; and HBeAg, positive. The serum level of the alpha-fetoprotein was 182.9
ng/ml (normal range, 0.0-8.1 ng/ml). An initial abdominal computed tomography (CT)
showed round, highly enhanced nodules within a dilated proximal common hepatic
duct (CHD) and left hepatic duct (LHD) at segments 3 and 4 without ductal dilatation
of the right lobe (Fig. 1A). These laboratory and imaging findings were consistent with
intraductal invasive HCC. On the patient’s 14th day of hospitalization, the first TACE
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Awas performed. During the TACE, an ill-defined curvilin-
ear tumor staining was shown at segments 3 and 4, which
extended along the left main portal vein on a selective left
hepatic angiography (Fig. 1B). After the superselection of a
main feeding artery from the left hepatic artery with a 3 Fr
microcatheter (Terumo Co., Tokyo, Japan), a continuous
infusion with 50 mg of cisplastin (Il-dong, Seoul, Korea )
was performed for 15 minutes. Next, 10 ml of a mixture
comprising 7 cc of iodized oil (Lipiodol; Laboratoire Andre
Guerbet, Aulnaysous Bois, France) and 40 mg of doxoru-
bicin hydrochloride (Adriamycin; Il-dong) were infused
until the compact lipiodol uptake of the tumor was
complete. In addition, the left hepatic artery, which was
the main feeder, was occluded by 500 EA of gelfoam
sponge particle (Gelfoam; Johnson & Johnson, Skipton,
England), which was soaked in a mixture of doxorubicin
hydrochloride (10 mg) and mitomicin-C (2 mg) (Mitomicin;
Il-dong, Seoul, Korea). Finally, the scout image after the
TACE showed compact curvilinear lipiodol uptake along
left portal vein area. 
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Fig. 1. Acute obstructive cholangitis after transarterial chemoembolization in 62-year-old male.
A. Initial abdominal CT scan shows ovoid-shaped, highly enhancing invasive intraductal hepatocellular carcinoma in proximal common
hepatic duct and left hepatic duct with ductal dilation (black arrow). 
B. Selective left hepatic angiography performed during initial transcatheter arterial chemoembolization showed ill-defined, tumor staining
along proximal common hepatic duct and left hepatic duct (black arrows). Tumor staining occurred in identical location of bile duct
invasion on CT image.
C. Follow-up abdominal CT performed one week after initial transcatheter arterial chemoembolization showed multifocal, dense lipiodol
deposits within proximal common hepatic duct and left hepatic duct after initial transcatheter arterial chemoembolization (black arrow).
We also found small, faint, parenchymal lipiodol deposits in peripheral portion of left lobe. 
D. Follow-up abdominal CT performed two weeks after initial transcatheter arterial chemoembolization showed acutely dilated proximal
common bile duct and left hepatic duct without visualization of previous lipiodol deposits at same level (black arrow).
CDTwo days after the TACE, the patient complained of a
fever, cough, and abdominal pain. The laboratory findings
demonstrated an acute marked elevated alkaline
phosphatase (1,015 IU/L), erythrocyte sedimentation rate
(103 mm/hr), and serum total bilirubin (3.3 mg/dl). An
abdominal CT performed one week after the first TACE
showed multiple compact lipiodol deposits within proximal
CHD and LHD (Fig. 1C). In spite of the supportive
management for fever and abdominal pain over several
days, the patient suffered from persistent abdominal pain
and jaundice. A follow-up abdominal CT two weeks after
the TACE showed an acutely dilated CHD and proximal
CBD which had acutely increased since the previous CT
examination. Moreover, the lipiodol deposits were not
visualized at the same level (Fig. 1D). In addition, an
obstructive dense lipiodolized tumor fragment (1 cm) was
observed in the distal CBD (Fig. 1E). The percutaneous
transbiliary drainage (PTBD) was performed for relief of
obstructive jaundice two days after the CT. As a result, the
cholangiography of the PTBD showed an ovoid large
filling defect in the distal CBD with complete obstruction
of the distal passage of contrast material (Fig. 1F). We
planned the percutaneous removal of the migrated tumor
fragment via the PTBD tract rather than endoscopic
removal due to the patient’s dyspnea. Three days after the
PTBD, we performed the percutaneous removal of the
tumor fragment in the distal CBD using a 1 cm biliary
stone basket (Cook, Bloomington, IN) via an 8 Fr biliary
sheath. During the procedure, the small part of the tumor
fragment was removed percutaneously since most parts of
the tumor fragment were not captured and removed by the
stone basket due to the toothpaste-like character of the
tumor fragment. An 8F aspiration catheter was then used
for aspiration of the tumor fragment from the distal CBD.
Subsequent to these procedures, a final cholangiography
revealed complete disappearance of the tumor fragment in
the distal CBD, followed by the restoration of normal
contrast passage via the ampulla of Vater (Fig. 1G). We
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Fig. 1. Acute obstructive cholangitis after transarterial chemoembolization in 62-year-
old male.
E. Same abdominal CT showed distally migrated, dense lipiodolized tumor fragments
in distal common bile duct (black arrow), which was completely obstructed in distal
common bile duct and resulted in dilatation of proximal common bile duct, left hepatic
duct, and gallbladder. 
F. Percutaneous transhepatic biliary drainage was performed for treatment of obstruc-
tive jaundice. Cholangiography of percutaneous transbiliary drainage showed ovoid,
large filling defect in distal common bile duct with complete obstruction of distal
passage of contrast (black arrow). 
G. Final cholangiography performed after these procedures showed complete
disappearance of tumor fragment in distal common bile duct, restoration of contrast
passage into duodenum, and decompressed biliary tree (black arrow). 
Gsuspected that the tumor fragment was crushed after
capture in the stone basket, which facilitated aspiration by
the aspiration catheter. Following the tumor aspiration, the
patient’s symptoms including the jaundice, fever, cough,
and abdominal pain subsided immediately and the labora-
tory values indicative of cholangitis gradually improved.
The PTBD tube was removed seven days after the
procedure and the patient was subsequently discharged. At
the time of discharge, the laboratory values were as
follows: alkaline phosphatase, 605 IU/L; and total serum
bilirubin, 1.2 mg/dL. The pathologic diagnosis of the
removed tumor fragment showed a total necrotic HCC. 
DISCUSSION
The presence of jaundice in a patient with intraductal
invasive HCC is an uncommon manifestation at the time of
diagnosis which usually occurs in later stages (1-3). HCC
may involve the biliary tract in several different ways:
tumor thrombi, hemobilia, tumor compression, or diffuse
tumor infiltration. Infrequently, jaundice may also result
from the external compression of the major bile ducts by
direct tumor encasement or by the metastatic
lymphadenopathy at the porta hepatis.
Histopathologically, intraductal tumor invasion shows
features resembling the viable HCC in the liver
parenchyma (4-6). 
A few cases have reported the incidence of a necrotic
tumor detaching from the bile duct wall, which migrated
into the distal CBD and caused obstructive jaundice (2, 7).
Further, the successful management of this with the
interventional procedure was rare. 
In our case, a subsequent abdominal CT scan and cholan-
giography of the PTBD revealed lipiodolized migrating
necrotic tumor fragments in the distal CBD due to an
apparent ischemic effect of lipiodol and gelfoam particles
after a TACE for bile duct invasive HCC.
A TACE induces marked ischemic necrosis in HCC;
however, its effect is apparently not limited to the tumoral
vascular bed, as shown by the importance of bile duct
injuries observed in an autopsy study of cirrhotic subjects
treated by TACE (8). Recently, several reports have
demonstrated the clinical efficacy and significant prolonged
survival rate of patients after hepatic arterial chemother-
apy, combined with 5-FU, adriamycin, and cisplastin in
inoperable HCC patients (9, 10) 
Patients with primary liver cancer and jaundice due to
tumor invasion in the bile duct may benefit from a surgical
resection. The goals of the surgical intervention include
biliary decompression with removal of tumor debris or
tumor-containing blood clots, and if possible, curative
resection of the hepatic tumor. The commonly used
operative methods are a lobectomy, hepatectomy plus a
thrombectomy, choledochotomy with Y-tube drainage
alone, or biliary diversion (11, 12). 
Several non-surgical methods exist for treatment of
migrated tumor fragments in the bile duct, caused obstruc-
tive jaundice in inoperable patients. Between the PTBD
and endoscopic biliary drainage methods, the latter is
usually performed as an initial treatment. However, the
difference in survival between the two methods in the
treatment of obstructive jaundice in HCC patient, is still a
matter of debate (13, 14). The necessity of removing a
migrating tumor fragment without symptoms is debatable
because there is no existing comprehensive report of gross
and pathologic features for a migrating tumor fragment in
the CBD.
In our case, we performed a right PTBD and subsequent
percutaneous removal using a biliary stone basket and
aspiration catheter. During the removal procedure, the
effect of the stone basket on the tumor fragment was
highly effective in terms of maceration and fragmentation,
which was helpful for the aspiration of tumor fragments
and spontaneous expulsion into the duodenum. As a result,
biliary obstruction was relieved and the intraductal lesion
disappeared. During two years of follow-up, the patient
showed no evidence of tumor recurrence or recurrent bile
duct dilatation on abdominal CT.
As a general guideline, the results of this study bring to
light the possible complications of treating an intraductal
invasive HCC by TACE which should be made aware to
the interventional radiologist for consideration.
Nevertheless, subsequent interventional treatment, includ-
ing PTBD with percutaneous removal, may be helpful in
the management of obstructive cholangitis after a TACE.
Most patients will have satisfactory palliation as well as the
occasionally cure and long-term survival if the appropriate
procedures are selected and executed safely.
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